Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of CTS3497 in MTAP-deleted advanced solid tumors and lymphoma
CTR20244544Phase 2Active
- Sponsor
- Sailan Bio
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CTS3497 in Nonhematologic neoplasms, lymphoma, sponsored by Sailan Bio. Started Jan 2025; status: active.
02
Drugs
CTS3497
03
Conditions
Nonhematologic neoplasmslymphoma
Beyond the preview
Go deeper on CTR20244544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244544.